AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment.

MLA

Caputo, Emilia, et al. “AurkA Inhibitors Enhance the Effects of B-RAF and MEK Inhibitors in Melanoma Treatment.” Journal of Translational Medicine, vol. 12, July 2014, p. 216. EBSCOhost, https://doi.org/10.1186/s12967-014-0216-z.

APA

Caputo, E., Miceli, R., Motti, M. L., Taté, R., Fratangelo, F., Botti, G., Mozzillo, N., Carriero, M. V., Cavalcanti, E., Palmieri, G., Ciliberto, G., Pirozzi, G., & Ascierto, P. A. (2014). AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment. Journal of Translational Medicine, 12, 216. https://doi.org/10.1186/s12967-014-0216-z

Chicago

Caputo, Emilia, Roberta Miceli, Maria Letizia Motti, Rosarita Taté, Federica Fratangelo, Gerardo Botti, Nicola Mozzillo, et al. 2014. “AurkA Inhibitors Enhance the Effects of B-RAF and MEK Inhibitors in Melanoma Treatment.” Journal of Translational Medicine 12 (July): 216. doi:10.1186/s12967-014-0216-z.